(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;desacetylcefotaxime;Cefotaxime impurity;3-Desacetyl CefotaxiMe;Cefpirome Sodium Impurity 1;Cefotaxime Sodium EP Impurity B;Deacetylcefotaxime,Cefotaxime Impurity B (EP);Cefotaxime Impurity 2(Cefotaxime EP Impurity B);(7R)-7-[[[(2-Amino-4-thiazolyl)(methoxyimino)methyl]carbonyl]amino]-3-(hydroxymethyl)cepham-3-ene-4-carboxylic acid;(6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-(MethoxyiMino)acetyl]aMino]-3-(hydroxyMethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;desacetylcefotaxime
Cefotaxime EP Impurity Bis a fully characterized chemical compound used as a reference standard of API Cefotaxime. The standard offered is compliant with regulatory guidelines.Cefotaxime EP Impurity Bis used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 66340-28-1
